"Radiation concerns weigh heavily in the decision processes of European customers. Because our Quantum Sniffers do not use a radioactive source, they become a natural choice for European security equipment purchasers. Our desktop model's intuitive and easy-to-use interface is a strong competitive advantage for our product and proved to be a key factor in the purchase decision," stated Implant Sciences' Global Vice President of Sales and Marketing Darryl Jones.
In November of 2011, the European Union banned the use of X-ray technology for security screening purposes in European airports due to radiation risks and concerns.
"Aviation security was a primary target when we developed the QS-B220. We are excited by the attention we are receiving in this important market, and look forward to the continued growth of the list of countries where the system is deployed," added Implant Sciences' President and CEO, Glenn D. Bolduc.
The Quantum Sniffer QS-B220
The QS-B220, introduced in May 2011, is a desktop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.